Completed PHASE1 INTERVENTIONAL 1-arm NCT03402087

A Study to Investigate BMS-986165 and Methotrexate in Healthy Male Patients

An Open-Label, Single-Sequence Study to Investigate the Effects of BMS-986165 on the Single-Dose Pharmacokinetics of Methotrexate in Healthy Male Subjects

Sponsor: Bristol-Myers Squibb

Conditions Lupus Psoriatic Arthritis

Interventions BMS-986165 Leucovorin Methotrexate

Updated 8 times since 2018 Last updated: Feb 24, 2020 Started: Jan 8, 2018 Primary completion: Mar 20, 2018 Completion: Mar 25, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Lupus and Psoriatic Arthritis and is currently completed. Bristol-Myers Squibb leads this study, which shows 8 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Mar 2020 — Jan 2021 [monthly]

Completed PHASE1
Jun 2018 — Mar 2020 [monthly]

Completed PHASE1

▶ Show 3 earlier versions

May 2018 — Jun 2018 [monthly]

Completed PHASE1

Status: Recruiting → Completed
Mar 2018 — May 2018 [monthly]

Recruiting PHASE1

Status: Not Yet Recruiting → Recruiting
Feb 2018 — Mar 2018 [monthly]

Not Yet Recruiting PHASE1

First recorded

Jan 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bristol-Myers Squibb

Data source: Bristol-Myers Squibb

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Groningen, Netherlands